Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Donald Jensen and Nancy Reau.
Connection Strength

2.674
  1. The American Association for the Study of Liver Diseases: A history of the first 10 years and its presidents. Hepatology. 2022 09; 76(3):854-859.
    View in: PubMed
    Score: 0.832
  2. Generic medications for hepatitis C. Liver Int. 2016 07; 36(7):925-8.
    View in: PubMed
    Score: 0.555
  3. Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014 Apr; 59(4):1246-9.
    View in: PubMed
    Score: 0.472
  4. Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin. Am J Gastroenterol. 2008 Aug; 103(8):1981-8.
    View in: PubMed
    Score: 0.321
  5. Vanishing bile duct syndrome. Clin Liver Dis. 2008 Feb; 12(1):203-17, x.
    View in: PubMed
    Score: 0.310
  6. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
    View in: PubMed
    Score: 0.104
  7. Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatology. Hepatology. 2016 12; 64(6):2210-2218.
    View in: PubMed
    Score: 0.035
  8. Hepatitis C virus: a critical appraisal of new approaches to therapy. Hepat Res Treat. 2012; 2012:138302.
    View in: PubMed
    Score: 0.027
  9. Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis. Gastroenterol Hepatol (N Y). 2006 Jul; 2(7):504-508.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.